Hyperbaric oxygen treatment for mastectomy flap ischaemia: A case series of 50 breasts
Diving and Hyperbaric Medicine Journal · 31.03.2021 · 51 (1) · 2-9
DOI: 10.28920/dhm51.1.2-9 ↗Kurz gefasst
Fallbericht in der Zeitschrift Diving and Hyperbaric Medicine Journal, online erschienen am 31.03.2021. Verfasst von Nicole E Spruijt und 3 weiteren Autor:innen. Beteiligte Einrichtung: Da Vinci Clinic, Geldrop, the Netherlands. Hauptthemen laut MEDLINE: Breast Neoplasms, Hyperbaric Oxygenation, Mammaplasty. Die Arbeit wurde bisher 19-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Hyperbaric oxygen treatment (HBOT) has been suggested as an effective intervention to limit necrosis of ischaemic skin flaps after mastectomy. The purpose of this study was to evaluate outcomes of HBOT in the largest series of patients to date with mastectomy flap ischaemia.
Methods
A retrospective analysis was performed of 50 breasts requiring HBOT for mastectomy flap ischaemia. The severity of the ischaemia or necrosis was evaluated by four independent observers using the skin ischaemia necrosis (SKIN) score. Multivariate logistic regression analyses were used to assess associations between risk factors and re-operation.
Results
HBOT was started a median of 3 days (range 1–23) after surgery and continued for a median of 12 sessions (range 6–22). The breast SKIN surface area scores (n = 175 observations by the independent observers) improved in 34% (of observations) and the depth scores deteriorated in 42% (both P < 0.01). Both the surface area and depth scores were associated with the need for re-operation: higher scores, reflecting more severe necrosis of the mastectomy flap, were associated with increased need for re-operation. Twenty-nine breasts (58%) recovered without additional operation. Pre-operative radiotherapy (OR 7.2, 95% CI 1.4–37.3) and postoperative infection (OR 15.4, 95% CI 2.6–89.7) were risk factors for re-operation in multivariate analyses.
Conclusions
In this case series, the surface area of the breast affected by ischaemia decreased during HBOT, and most breasts (58%) did not undergo an additional operation. A randomised control trial is needed to confirm or refute the possibility that HBOT improves outcome in patients with mastectomy flap ischaemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Da Vinci Clinic, Geldrop, the Netherlands.
- Corresponding author: Dr Nicole E Spruijt, Da Vinci Clinic, Nieuwendijk 49, 5664HB Geldrop, the Netherlands, n.spruijt@davincikliniek.com.
- Department of Plastic, Reconstructive and Hand Surgery, Maastricht UMC+, the Netherlands.
- Department of Plastic, Reconstructive and Hand Surgery, Maxima Medical Center Eindhoven, the Netherlands.
- Department of Plastic, Reconstructive and Hand Surgery, Catharina Hospital, Eindhoven, the Netherlands.
Zitieren
APA
Spruijt, N. E., Hoekstra, L. T., Wilmink, J., & Hoogbergen, M. M. (2021). Hyperbaric oxygen treatment for mastectomy flap ischaemia: A case series of 50 breasts. Diving and Hyperbaric Medicine Journal, 51(1), 2-9. https://doi.org/10.28920/dhm51.1.2-9
Vancouver
Spruijt NE, Hoekstra LT, Wilmink J, Hoogbergen MM. Hyperbaric oxygen treatment for mastectomy flap ischaemia: A case series of 50 breasts. Diving and Hyperbaric Medicine Journal. 2021;51(1):2-9. doi:10.28920/dhm51.1.2-9
BibTeX
@article{Spruijt2021,
author = {Spruijt, Nicole E and Hoekstra, Lisette T and Wilmink, Johan and Hoogbergen, Maarten M},
title = {Hyperbaric oxygen treatment for mastectomy flap ischaemia: A case series of 50 breasts},
journal = {Diving and Hyperbaric Medicine Journal},
year = {2021},
volume = {51},
number = {1},
pages = {2--9},
doi = {10.28920/dhm51.1.2-9}
}
EUVIMED